Created in 1998 in the context of the introduction of the T2A activity-based pricing approach, Groupe PSIH is a leader in the management of Healthtech facilities in France, with a presence in more than 1,000 hospitals.

Positioned in the strategic Healthtech data market, the group has expanded its activity to include Healthtech data hosting with the acquisition of IDS, and is developing new services around the valuation of Healthtech data in hospitals.

The majority stake acquired by Lauxera, together with the Nov Santé fund and Relyens, will enable Groupe PSIH, which was founded by Ludovic de Saint Jean, to speed up its development while remaining under French control, at a time when Healthtech data has taken on strategic and sovereign importance.

Paris (France) and San Francisco (United States), 14 September 2021 – Lauxera Capital Partners announces it has made an investment in Groupe PSIH, the fourth investment by Lauxera Growth I, its growth and growth buy-out fund dedicated to investment in the European Healthtech sector.

This is Lauxera’s first majority stake, which it has made alongside founder and CEO Ludovic de Saint Jean who is reinvesting, Eurazeo via the Nov Santé Actions Non Cotées fund launched by the French Insurance Federation and Caisse des Dépôts, and Relyens, a leading European mutual group in insurance and risk management for Healthtech players and local authorities.

A champion of software solutions for managing Healthtech institutions

Founded in 1998 by Ludovic de Saint Jean and based in Lyon, Groupe PSIH has established itself as a French champion in decision-making software, supporting Healthtech professionals in the management of hospitals. Initially focused on data in the context of the information system medicalisation programme (PMSI), the Group has expanded its offering in response to the growing complexity of the strategic and operational challenges facing Healthtech institutions. Groupe PSIH’s solutions provide a 360-degree view of all Healthtech data and have been adopted by more than 1,000 Healthtech facilities, 25 teaching hospitals, 13 cancer centres and 105 regional hospital groups.

A growing business, driven by its historic market and entry into new segments

With turnover of nearly €11 million in 2020, Groupe PSIH shows steady growth in both its historical activity and in new business in buoyant market segments. It currently has a team of 70 employees, including a strong component of computer engineers and data scientists. In addition to its Lyon roots, the company also has an R&D office in Canada (Montreal). In 2019, PSIH acquired IDS, a health data hosting operator. The Group has also developed internally a range of high value-added management software for niche markets, such as PlaniPSY for the segment of care without consent.

The opportunity to build a leading national technological platform for health data

With the financial and operational support of its three new investors, PSIH will pursue growth in its markets, drawing on acquisitions where necessary. By capitalising on its knowledge of data in hospitals, PSIH aims to develop new data-based services to become a leading French multi-service platform.

“I am particularly impressed by PSIH’s development since its creation under the impetus of Ludovic de Saint Jean and his teams, who have built a leader whose solutions contribute in particular to the efficiency of Healthtech facilities”, says Pierre Moustial, Chairman and co-founder of Lauxera Capital Partners. “As a Tibicertified fund involved in the expansion of rising players in the French Healthtech sector, Lauxera offers PSIH an all-French solution in terms of capital to build a champion in health data and become a player in managing the sovereignty of French Healthtech data.”

“Lauxera’s majority shareholding alongside the Nov Santé fund and Relyens marks a new stage in the development of PSIH. The experience of these investors will be particularly valuable in supporting the growth of our Group and speeding up deployment of the innovative solutions designed by our leading-edge teams to serve Healthtech institutions.” says Ludovic de Saint Jean, founder of Groupe PSIH.

“Groupe PSIH is an example of a successful French operator in Healthtech data management, particularly in public hospitals, contributing to better management of facilities with severely constrained budgets. Eurazeo is honoured to be able to support Ludovic de Saint Jean and contribute to the development of PSIH in Healthtech data areas of growing importance, to improve the efficiency of hospitals and of Healthtech data for patients,” adds Arnaud Vincent, Managing Director, Nov Santé, Eurazeo.

In the words of Dominique Godet, Chief Executive Officer of Relyens: “This investment echoes our Group’s mission statement “to act and innovate alongside those who work for the common good to build a world of trust”. Thanks to data analysis, the use of artificial intelligence tools, swift processing and technological advances, it is now possible to reduce or even avoid risks, while helping to enhance performance.”